Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.
A new study finds that anticholinergic drugs, like antidepressants and antipsychotics, are associated with mild cognitive decline.
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.
A new study finds adverse long-term consequences associated with the increased use of antipsychotics in first-episode psychosis.
A new study finds that adding an antipsychotic to existing antidepressant treatment is associated with a 45% increased risk of early death.
Royal College of Psychiatrists’ former president demands support for patients coming off antidepressants.
Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.
MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.
Taking an SSRI antidepressant was associated with a 26% increased risk of violent crime conviction.
A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.
A new study suggests that taking antidepressants impairs empathy, while the experience of depression itself does not.
MIA's Ana Florence interviews recovery advocate Ro Speight about her journey from receiving Peer Support to working as a facilitator in Peer Partnered Open Dialogue.
Gender identity conversion efforts impact psychological distress and lifetime suicidality in transgender people.
A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.
Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.
In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.
A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
Studies that compare the effectiveness of different antidepressant drugs are unreliable, according to new research in BMC Psychiatry.
New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.
Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...
A new study tracks the approval of the latest antidepressant, vortioxetine, by the Federal Drug Administration (FDA) and the European Medicines Agency (EMA). The...
A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.
Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.